Related Experiment Video
Updated: Apr 27, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Exhaled HPV infection in lung cancer: role of MA at 3p
Giovanna E Carpagnano1, Donato Lacedonia1, Elisabetta Crisetti1
1Department of Medical and Surgical Sciences, Institute of Respiratory Disease, University of Foggia, Foggia, Italy.
Background And Aims:
Lung cancer has recently been associated with human papilloma virus (HPV) infection. The most important event associated with HPV infection in cancer foresees HPV DNA integration into the host genome. Sites of integration such as the fragile site FRA3B adjacent to the FHIT frequently undergo microsatellite alterations (MAs). In this study we aim to verify the role of MAs at 3p in non-small cell lung cancer (NSCLC) with HPV positivity and eventual correlation with sex, histotype, TNM stage and cigarette smoking.
Methods:
We enrolled 26 NSCLC patients previously investigated for the presence of HPV in their airways (11 HPV+ and 15 HPV-). All subjects had allelotyping analysis of DNA from exhaled breath condensate (EBC), blood and bronchial brushing of microsatellite D3S1300 located in the chromosomal region 3p.
Results:
For the first time we described the presence of MAs at 3p in EBC of NSCLC patients with HPV positivity. MAs in EBC corresponded to those in paired brushing. The number of patients with 3p MAs was higher in the group of NSCLC with HPV positivity than with HPV negativity. No relationship between the presence and type of MAs in EBC-brushing/DNA and sex, histotype or tumor stage was found.
Conclusion:
Our results suggested that MAs at 3p are present in caucasic NSLC HPV+ patients and might be involved in lung carcinogenesis. In consideration of the possible clinical usefulness of the analysis of MAS at 3p in the EBC of HPV+ patients in the non-invasive screening for lung cancer, these results merit further studies.
Insights
Microsatellite alterations (MAs) at 3p are present in the exhaled breath condensate of non-small cell lung cancer (NSCLC) patients positive for human papilloma virus (HPV). These MAs may play a role in lung carcinogenesis and could be useful for non-invasive screening.
Area of Science:
- Oncology
- Genetics
- Virology
Background:
- Human papilloma virus (HPV) infection is increasingly linked to lung cancer development.
- HPV DNA integration into the host genome is a critical event in oncogenesis.
- Fragile sites like FRA3B, near FHIT, are prone to microsatellite alterations (MAs) upon HPV integration.
Purpose of the Study:
- To investigate the role of MAs at chromosomal region 3p in non-small cell lung cancer (NSCLC) with HPV positivity.
- To explore correlations between 3p MAs and clinical factors such as sex, histotype, TNM stage, and smoking status.
Main Methods:
- Allelotyping analysis of microsatellite D3S1300 at 3p was performed on DNA from exhaled breath condensate (EBC), blood, and bronchial brushing.
- 26 NSCLC patients were analyzed, categorized into HPV-positive (11) and HPV-negative (15) groups.
Main Results:
- The study identified MAs at 3p in the EBC of HPV-positive NSCLC patients for the first time.
- MAs detected in EBC samples corresponded with those in paired bronchial brushing samples.
- A higher prevalence of 3p MAs was observed in HPV-positive NSCLC patients compared to HPV-negative patients.
- No significant correlation was found between MAs and patient sex, histotype, or tumor stage.
Conclusions:
- MAs at 3p are present in Caucasian NSCLC patients with HPV positivity and may contribute to lung carcinogenesis.
- Analysis of 3p MAs in EBC of HPV-positive patients shows potential for non-invasive lung cancer screening.
- Further research is warranted to validate the clinical utility of 3p MA analysis in EBC for lung cancer detection.
More Related Videos
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs